🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the absence of irritation poten...
Status
Completed
Location
Sanofi-aventis administrative office
Start Date
2007-12
Trial ID
NCT00668577
Treatments Being Tested
Patients with an impaired blood supply of the heart routinely receive oxyge...
Status
Completed
Location
Bern University Hospital
Start Date
2014-10-01
Trial ID
NCT02233634
Treatments Being Tested
Novel approaches to improve TB treatment outcomes (to reduce morbidity, mor...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2016-09
Trial ID
NCT02781909
Treatments Being Tested
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
This phase I trial studies the side effects and best way to give metformin ...
Status
Withdrawn
Location
Fox Chase Cancer Center
Start Date
TBD
Trial ID
NCT02050009
Treatments Being Tested
The purpose of this study is to determine if the addition of apalutamide to...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-27
Trial ID
NCT02489318
Treatments Being Tested
The purpose of this study is to demonstrate the absence of irritation poten...
Status
Completed
Location
Sanofi-aventis administrative office
Start Date
2007-11
Trial ID
NCT00668460
Treatments Being Tested
The purpose of this study is to reconstruct a 12-lead electrocardiogram (EC...
Status
Completed
Location
UPMC Presbyterian
Start Date
2007-11
Trial ID
NCT00890461
Treatments Being Tested
To understand the safety and efficacy of Revlimid® Capsules 2.5 mg and 5 mg...
Status
Completed
Location
ASO KK Iizuka Hospital
Start Date
2017-05-30
Trial ID
NCT03098589
Treatments Being Tested
Use lay language. Oxaliplatin is a reference anticancer drug in the treatme...
Status
Completed
Location
CHU de Clermont-Ferrand
Start Date
2013-02-02
Trial ID
NCT01775449
Treatments Being Tested